Doxorubicin Hydrochloride Liposome Combined With Irinotecan Versus VIT Regimen in the Treatment of Pediatric Rhabdomyosarcoma
Condition: Rhabdomyosarcoma, Child Interventions: Drug: Doxorubicin Hydrochloride Liposome+Irinotecan; Drug: Temozolomide+Irinotecan+Vincristine Sponsors: Sun Yat-sen University; CSPC Ouyi Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials